UNSPSC 51281812: Zorubicin

This classification denotes an anthracycline antibiotic with the molecular formula C34H35N3O10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V25F9362OP, chemically known as rp-22,050 hydrochloride but generally known as zorubicin, which bears US NIH Compound Identifier 6540456. European Medicines Agency schedules Zorubicin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00190MIG.

UNSPSC 51281812 Zorubicin is a Commodity code that nominally identifies a specific pharmaceutical product, but recent state and local procurement activity under this code does not center on zorubicin itself. Instead, the code tags solicitations for a broader mix of pharmaceutical products and medical supplies — naloxone, generic multi-source pharmaceuticals, over-the-counter products, and emergency-response medical consumables including respiratory equipment, cardiac monitoring electrodes, endotracheal tubes, and bandaging materials. State and local issuing bodies soliciting under the code include county health departments (Seminole County, Florida), state health and human services agencies (Texas Health and Human Services Commission), municipal fire and rescue departments (Tampa Fire Department), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving state and local government facilities across multiple states including Oregon). The work ranges from direct-purchase solicitations for consumable supplies to request-for-information (RFI) processes for pharmacy benefit program design, indicating that code application varies widely across jurisdictions and procurement phases.

Recent activity spans Florida, Texas, Minnesota, and Oregon. Representative recent opportunities include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023 (posted June 30, 2026); the City of Tampa's IFB for 169 line items of medical and first aid supplies for the Fire Department Rescue Division with a $700,000.00 estimated contract amount, response due March 13, 2026, designated as a sheltered-market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount; the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026; and the Texas Health and Human Services Commission's RFI regarding direct-to-manufacturer prescription programs, posted April 3, 2026. The code shows active state and local procurement but with heterogeneous product scope — pursue only if your firm's capabilities align with the specific medical product or service categories within individual solicitations rather than zorubicin narrowly.